These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1226967)

  • 21. Hepatitis associated antigen in cases of banal and chronic hepatitis and in cases of cirrhosis.
    Demeulenaere M
    Arch Fr Mal App Dig; 1971 Dec; 60(12):670-2. PubMed ID: 5158157
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of chronic liver diseases with the presence of serum markers of the hepatitis B virus].
    Aprosina ZG; Lopatkina TN; Iakovenko EP; Krel' PE; Saiapina ES
    Ter Arkh; 1988; 60(11):23-8. PubMed ID: 3238571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Infectivity of serum containing HBsAg and antibody to e antigen.
    Berquist KR; Maynard JE; Murphy BL
    Lancet; 1976 May; 1(7967):1026-7. PubMed ID: 57433
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australia antigen and circulating antibodies in chronic aggressive hepatitis.
    Findor J; Igartua EB; Alonso A; Domecq R; Bozzola C
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):98-102. PubMed ID: 4201582
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognosis for the patients with chronic hepatitis B.
    Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
    Coll Antropol; 2000 Jun; 24(1):211-6. PubMed ID: 10895548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Australia antigen and liver disease: a review article.
    Edington GM
    J Trop Med Hyg; 1973 Oct; 76(10):270-2. PubMed ID: 4149492
    [No Abstract]   [Full Text] [Related]  

  • 29. Southern-blot analysis and simultaneous in situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver disease.
    Han KH; Hollinger FB; Noonan CA; Solomon H; Klintmalm GB; Genta RM; Yoffe B
    Hepatology; 1993 Nov; 18(5):1032-8. PubMed ID: 8225208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of hepatitis B virus infection in chronic glomerulonephritis].
    Kiperova B; Grouev I; Krastev Z; Naoumov N; Minkova V; Mateva L; Maleev A
    Ann Med Interne (Paris); 1989; 140(5):380-2. PubMed ID: 2688509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical significance of determining antigens and antibodies to hepatitis B viruses using radiosaturation analysis in chronic liver diseases].
    Stránský J; Vodák M; Zichová M; Hrbác I; Sprincl L
    Cas Lek Cesk; 1984 Dec; 123(51):1561-5. PubMed ID: 6518471
    [No Abstract]   [Full Text] [Related]  

  • 36. [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study].
    Perret JL; Moussavou-Kombila JB; Delaporte E; Pemba LF; Boguikouma JB; Matton T; Larouze B
    Gastroenterol Clin Biol; 2002 Feb; 26(2):131-5. PubMed ID: 11938063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Data on hepatitis antigen (HAA)].
    Renger F; Reimann W; Frank J; Kobe E; Vogel C; Vogel H; Kayser W; Bosse W; Geyer F
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):83-6. PubMed ID: 4347640
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B (Australia) antigen--current clinical and epidemiological concepts.
    Patterson CP; Maynard JE; Berquist KR
    Ariz Med; 1974 Apr; 31(4):258-62. PubMed ID: 4364465
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Virus-like particles in HBsAg-positive-chronic aggressive hepatitis and liver cirrhosis.
    Yamada G; Tobe K; Kobayashi T; Ohta Y; Kosaka K
    Gastroenterology; 1976 Jan; 70(1):149. PubMed ID: 1245280
    [No Abstract]   [Full Text] [Related]  

  • 40. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.